Author

J. K. Fiege

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

J. Daniel· 2 shared R. A. Langlois· 2 shared A. C. Nelson· 1 shared B. Auch· 1 shared B. K. Thielen· 1 shared D. Johnson· 1 shared D. M. Gohl· 1 shared E. J. Fay· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J. Daniel

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium

J. K. Fiege, J. M. Thiede, H. Nanda, W. E. Matchett, P. J. Moore, N. R. Montanari, B. K. Thielen, J. Daniel, E. Stanley, R. C. Hunter, V. D. Menachery, S. S. Shen, T. D. Bold, R. A. Langlois

This study investigates SARS-CoV-2 tropism, antiviral responses, and therapy effectiveness in human airway epithelium using single-cell RNA-sequencing and flow cytometry.

bioRxiv · Oct 19, 2020Microbiology

Analytical Validation of a COVID-19 qRT-PCR Detection Assay Using a 384-well Format and Three Extraction Methods

A. C. Nelson, B. Auch, M. Schomaker, D. M. Gohl, P. Grady, D. Johnson, R. Kincaid, K. E. Karnuth, J. Daniel, J. K. Fiege, E. J. Fay, T. Bold, R. A. Langlois, K. B. Beckman, S. Yohe

This study validates a qRT-PCR assay for SARS-CoV-2 detection using a 384-well format and three extraction methods, showing robust accuracy and sensitivity with commercial reagents.

bioRxiv · Apr 2, 2020 · PreprintPathology